Nursing Care of the NAS Infant. Lori Markham MSN, MBA, ARNP, NNP-BC



Similar documents
NEONATAL ABSTINENCE SYNDROME. Osama Naga, M.D. PGY2

NEONATAL ABSTINENCE SYNDROME AND SCORING SYSTEM

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13

Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal

Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010

Substance Use Guideline 4B PERINATAL OPIOID EXPOSURE, CARE OF THE NEWBORN

(peak at 2 days 6 wks)

Neonatal Abstinence Syndrome: Indian Health Service (IHS) Best Practices Guidelines

A guide for parents of babies at risk of Neonatal Abstinence Syndrome Planning care for you and your baby

CHILDREN S SERVICES. Neonatal Abstinence Syndrome

Treatment Guidelines for Neonatal Narcotic Abstinence Syndrome with Diluted Oral Morphine and Clonidine

4/28/2014. Care of the Opiate Exposed Newborn and Family Marybeth Tyler, NNP-BC, MS, IBCLC May, The reality: Poly drug exposure

BABIES BORN TO ADDICTED MOTHERS

Challenges of Foster Parents who Care for Infants with Neonatal Abstinence Syndrome

Substance Abuse lifestyle Concern for mother - fetus - and - neonate

Introduction to Neonatal Abstinence Syndrome

Wales Neonatal Network Guideline

Children s Specialized Hospital Neonatal Abstinence Syndrome (NAS)

10/18/2012. The Impact of Substance Use on Newborns. Objectives. Do Infants Exposed to Maternal Opioids Have Drug Addiction?

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

What is Methadone? Opioid Treatment Programs Today. Is Methadone Safe? Pain Clinics. Wisconsin OTPs. Methadone Maintenance Treatment 5/6/2013

Neonatal Abstinence Syndrome. A Guide for Families

NEONATAL ABSTINENCE SYNDROME (NAS)- THE CARE YOUR BABY MAY NEED

Management of Pregnancy. Opioid Addiction Treatment

Opioid/Opiate Dependent Pregnant Women

Neonatal Drug Withdrawal. John Wareham, MD Department of Neonatology, St. Vincent Women s Hospital

Welcome. How Do I Ask Questions? Agenda. Thank you for joining us today. The webinar will begin in a few moments.

Neonatal Abstinence Syndrome (NAS)

NNEPQIN Guideline for the Management of Labor, Delivery and the Newborn in the Opioid Dependent Pregnancy. March 2014

Objectives. Objectives, continued 9/22/2015

Incidence. Substance Abuse. Care of the Drug Exposed Infant National Survey on Drug Use and Health:

Magee-Womens Hospital

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

OFF TO A GOOD START: #9 Caring For the Drug Affected Infant

NHS FORTH VALLEY Management of Neonatal Abstinence Syndrome

Ethical Issues Related to Long-Term Consequences of Neonatal Abstinence Syndrome (NAS) Christopher Church, Ph.D.

Why is prematurity a concern?

V11.2 NPIC/QAS. Special Quarterly Report: Linked Analysis Neonatal Abstinence Syndrome

Downers/Depressants (pages 40-50)

SOUTH CENTRAL NEONATAL NETWORK GUIDELINE. South Central (North) Guideline for Neonatal Drug Withdrawal

UNIT VIII NARCOTIC ANALGESIA

Information About Benzodiazepines

3/31/2015. Objectives. Alcohol. Long term effects. Substance abuse increases the risk of: Substance Abuse in Pregnancy

Algorithm for Initiating Antidepressant Therapy in Depression

How To Treat A Drug Addiction

2013 Transforming Neonatal Drug Withdrawal

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

Neonatal Abstinence Syndrome Anthony E. Burgos and Bryan L. Burke, Jr. DOI: /neo.10-5-e222

The CCB Science 2 Service Distance Learning Program

Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

MANAGEMENT OF THE INFANT BORN TO THE DRUG-ABUSING MOTHER Version: 5 Ratification Date: Feb 2014 Review Date: Feb 2017 Approval:

Prevention and Treatment of Opioid and Benzodiazepine Withdrawal

Methadone and Pregnancy

Collaborative Care for Pregnant Women with Substance Use Disorders

Massachusetts Department of Public Health Guidelines for Community Standard for Maternal/Newborn Screening For Alcohol/Substance Use

Benzodiazepines: A Model for Central Nervous System (CNS) Depressants


Medication Assisted Treatment

10/19/15. Stephen Loyd, M.D., F.A.C.P Healthy Kingsport Meadowview Convention Center Kingsport, Tennessee October 17, 2015

From the street to the NICU. Richard Christensen, PA, CAS

Identifying and Managing Substance Use During Pregnancy

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal

Abstral Prescriber and Pharmacist Guide

Developing Human Fetus

Lora McGuire MS, RN Educator and Consultant Barriers to effective pain relief

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

March of Dimes. FAQ on Drug Use and Pregnancy. November < [accessed February 2010]

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]

Opioid Analgesics. Week 19

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?

This module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,

Substance-Exposed Newborns

MEDICATION ABUSE IN OLDER ADULTS

Objectives. Pain Management Knowing How To Help Yourself. Patients and Family Requirements. Your Rights As A Consumer

Naloxone treatment of opioid overdose

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Breastfeeding. Nursing Education

Caring for your baby in the NICU: feeding

COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE

SUBSTANCE ABUSE CONCERNS IN CHILD PROTECTION. Presenters: Melissa Kimball and Amy Kelly

CO-OCCURRING DISORDERS. Michaelene Spence MA LADC 8/8/12

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

SUPPORT OF BREASTFEEDING FAMILIES IN NICU THE WOMEN S HOSPITAL AT JACKSON MEMORIAL

About the Lactation Consultant Education Program

PATIENT TREATMENT AGREEMENT

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

CCW Task Order 16: Round 3 Clinical Condition Algorithms. Page 1 of 5 ICD-9 CODE DESCRIPTION ICD-9 CODE

Standard of Care: Neonatal Intensive Care Unit (NICU) Physical and Occupational Therapy Management of the high risk infant.

Objectives. What is NAS? What is NAS? Faculty Disclosure. Providing Optimal Care for Neonates with Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome: An Emerging Epidemic?

Medication-Assisted Addiction Treatment

Use of Buprenorphine in the Treatment of Opioid Addiction

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Heroin Addiction. Kim A. Drury RN, MSN

How babies' senses develop

Neonatal Abstinence Syndrome

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Transcription:

Nursing Care of the NAS Infant Lori Markham MSN, MBA, ARNP, NNP-BC

Objectives Define neonatal abstinence syndrome Recognize the clinical presentation Identify non-pharmacologic and pharmacologic caregiver strategies for managing neonates with NAS Learn techniques to minimize neuroexcitation during withdrawal

NAS What is it? Infants born to mothers with antepartum opioid use which develop withdrawal symptoms following the postpartum cessation of in utero exposure to opioids Continuous drug exposure during pregnancy 50-90% in babies born to heroin-dependent mothers 60% in babies born to mothers on methadone

Incidence of NAS JAMA. 2012;307(18):1934-1940 4

Drugs Associated with Symptoms in Newborns Opiates Heroin Methadone Buprenorphine Codeine OxyContin Percocet Dilaudid Fentanyl Benzodiazepines Valium Ativan Clonazepam Xanax Stimulants: Caffeine Nicotine Methamphetamine SSRI s: Prozac Celexa Paxil Zoloft Lexapro Barbiturates: Phenobarbital Luminal Marijuana Alcohol 5 2016.02

NAS Facts! Infants with NAS are 2.5 times more likely as uncomplicated term infant to be readmitted within 30 days Statistically identical to the late preterm infant Shorter hospital stays for NAS patients are associated with rate of readmission < 1 week hospital stay has the highest risk Protracted signs of withdrawal have been described in adults and newborns

Drug addiction is an illness Keep in mind why! Drugs are also used for medical reasons every day Mental illness Seizure disorders Pain Diagnoses Fibromyalgia Sickle cell disease Arthritis Endometriosis

Issues in the Newborn Period Nicotine Marijuana Opiates Alcohol Cocaine Methamphet amine Fetal Growth Effect No effect Effect Strong effect Effect Effect Anomalies No consensus on effect No effect No effect Strong effect No effect No effect Withdrawal No effect No effect Strong effect Strong effect No effect * Neurobehavior Effect Effect Effect Effect Effect Effect

Onset of Symptoms Drug Signs Onset of signs Duration Alcohol Heroin Benzodiazepines Barbituates Methadone Buprenorphine Cocaine Hyperactivity, crying, irritability, poor suck, tremors CNS irritation, GI tract dysfunction, tone Irritability, tremors, excessive crying, tone CNS irritation, GI tract dysfunction, tone Hyperactive Moro, jitteriness, excessive sucking 3-12 hours 18 months Within 24 hours May not start until 2 weeks ~ 6-7 days Sub acute 4-6 months 4-6 months 24-72 hours 7-14 days? 4 weeks Sub-acute 6 months 48-72 hours Up to 7 days Nicotine Excitable and hypertonic???? Antidepressants CNS, motor, respiratory, GI symptoms, hypoglycemia Hours to days after birth 1 4 weeks Caffeine Jitteriness, vomiting, tachypnea At birth ~ 1 week of age

Nursing Assessment Maternal history risk behaviors Toxicology Newborn behaviors WITHDRAWAL assessment Finnegan scoring

Diagnosis History Most useful and least reliable Urine Reflects intake only few days before delivery Meconium Drugs may be found up to 3 days after delivery Hair The most sensitive Not widely available

Complications Withdrawal or toxicity signs and symptoms in neonate Congenital anomalies Fetal growth restriction Increased risk of preterm birth Impaired neurodevelopment 1 2 2016.02

Co-Morbidities Differential Diagnosis No clinical signs should be attributed solely to withdrawal without appropriate assessment, evaluation, and diagnostic tests to rule out other cause Common neonatal disorders that mimic or compound NAS Milk intolerance Hypoglycemia Hypocalcemia Sepsis Meningitis Hypomagnesemia

Differential Diagnosis - Research Prematurity can increase or decrease score Finnegan tool was not designed for preemies Older NAS babies do not sleep three hours between feeds Trisomy 21 infant with major heart defects: large dose due to tachypnea, sweating and poor feeding some symptoms due to heart failure and genetics NAS baby scoring for fever and excoriation necrotizing fasciitis

Basic Supportive Care

Leave your bias outside the door Family Centered Care The family is a unit, these are the parents the baby has Meet your patient/family where they are. Build on their strengths and set them up for success A person s actions make sense in their context 16

Promote Bonding Engage the parents in the care point out behaviors to watch for that will help them be more responsive to their infant s needs Encourage parent visits praise their efforts to be at the bedside no matter what time it is Score infant with Mom present when possible explain behaviors and scores eliciting family participation promotes a team approach, and better understanding and bonding

Pediatric Therapy Services Advocate for Peds Therapy specialists to be involved Experts on sensory/motor behaviors Can help parents bond more effectively by explaining behaviors displayed by infants They bring additional tools to the bedside to enhance the infant s successful transition There is NO contraindication to their involvement

Environment - Handling Prepare everything prior to disturbing infant to minimize handling Use slow, modulated, gentle movements when handling infant Kangaroo care! Encourage parents to do this as it can drastically reduce Finnegan scores! A measure that can immediately quiet an infant is the Vertical Rock in care-giver s arms. Slowly, in a C position, rock up and down for just a few revolutions. It helps infant switch gears Utilize Cuddlers! Instruct them to hold infants close to their body gently, but firmly

Devices and Therapies Use pacifiers liberally Baths Can be for cleanliness as well as therapeutic. No limit on therapeutic baths! Utilize swaddling and plenty of water when bathing for optimum therapeutic effect! Utilize large tubs filled with enough water to submerge infant up to his/her shoulders Use blankets to bolster infant if a second pair of hands is not available Infant Massage It will quiet and calm your infant for hours can be done during a bath to intensify the therapeutic effect

Diaper/Skin care Skin Care be proactive always, every diaper change, use protective barrier Utilize a first line ointment as a protectant barrier; no friction cleaning A quick rinse with peri bottle of warm water keeps bottom clean and skin free of friction pat dry apply barrier

Non-pharmacologic Intervention

Non-pharmacologic Intervention Swaddling Rocking Minimal sensory or environmental stimulation Light and sound Maintaining temperature stability Breastfeeding Increasing the frequency of feeds May require 150 to 250 kcal/kg/day

Swaddling swaddle so infant can still move his/her arms and have hands to mouth for comfort utilize blanket rolls under the infant s thighs for support of extensor muscles use a C position if it is quieting for them explain swaddling measures and blanket rolls to parents Don t give mixed messages 24

Swings Swings should be used only as a last option Use slowest motion setting, use setting that most closely achieves front to back motion-it helps with vestibular maturation Mamaroos most therapeutic settings are car ride and Kangaroo. Adjust the swing to its most horizontal setting, place infant into swing on either side, not face forward, in order to achieve the best vestibular position while swing is in motion Music is not recommended for these infants, however, the ocean wave sounds do appear to soothe and deflect other noise When infant cries in a swing, it may be time to stop!

Environment Noise Maintain a quiet room, dim lighting, positive energy field, slow mindful movement Be conscientious in reducing noise when closing fridge door, bedside module drawers, and moving nutrition carts Avoid talking at or over bedsides when infants are sleeping, or feeding Leave normal to loud voice levels, laughter, and peripheral visiting outside the nurseries Maintain quiet even in the hallways outside the nurseries ADVOCATE for your babies! Remind personnel as necessary! Normal voice tones are loud inside quiet nurseries!

Nutrition Promote Breast Feeding! Refer to Lactation as needed- caution parents that abrupt cessation of BF may increase withdrawal signs and symptoms Ad Lib Demand Feeds Be careful not to over-feed at any one feeding Most term newborns do not go 4 hours between feedings, much more common to feed every 2-3 hours Feed on early hunger cues - decreases escalation of agitation, allows capture of quiet alert state which decreases energy usage 27

Tips for Feeding Swaddle infant snugly during feeds with hands forward but contained Infants are trying to do 4 things at once, 3 of those are breathing, sucking and swallowing which we as caregivers can t do for them; the 4th we can do! Control their environment so they can focus! Refrain from unnecessary conversation while feeding infant- it distracts their focus 28

Breastfeeding Guidelines Mother in residential or outpatient treatment adhering to treatment requirements has had negative urine screens and adequate prenatal care for at least 2 weeks prior to delivery Mother not in formal treatment program no use of cocaine, methamphetamines, PCP, or other drugs contraindicated in breastfeeding for at least one month prior to delivery has signed a release allowing the infant s care team to continue to review her toxicology screen results No other maternal contraindications Mother is HIV-negative and TB-negative Mothers are counseled not to use marijuana, tobacco, or alcohol while breastfeeding

Pharmacologic Intervention

When to start medication? AAP recommends starting when non-pharmacologic measures are not enough Relieve moderate to severe signs of NAS Prevent complications such as fever, weight loss and seizures No standard and thresholds vary Finnegan scale 8 x 3 scores Benefit: short-term amelioration of clinical signs Disadvantages: prolongs drug exposure and duration of hospitalization; may affect maternal-infant bonding

Most frequently used Oral morphine versus supportive care Morphine No significant effect of morphine on treatment failure rate Increased duration of treatment and length of hospital stay (LOS) Decreased number of days required to regain birth weight and duration of supportive care Widely variable pharmacokinetics Various formulations Neofax recommends 0.4 mg/ml dilution from concentrated oral morphine sulfate solution

Buprenorphine More recently investigated Primarily used in adults for withdrawal Partial mu opioid receptor agonist/antagonist Blocks the binding of other mu agonists Metabolism CYP 3A4 to an active metabolite, norbuprenorphine Available as sublingual tablets Extemporaneous compound available

Place in therapy Phenobarbital Drug of choice for nonnarcotic-related withdrawal Adjunctive therapy Benefits Modifies hyperactive behavior related to narcotic withdrawal Disadvantages Does not relieve gastrointestinal signs May depress the CNS Impairs suck reflex Delays bonding between mother and infant Long half life Drug interactions (inducer) Rapid tolerance to sedative effect Alcohol (13.5%)

Clonidine Centrally acting alpha2-adrenergic receptor agonist Used as adjunct therapy in opioid withdrawal in children and adults Inhibits CNS sympathetic outflow Ameliorates autonomic over-activity Tachycardia, hypertension, diaphoresis, restlessness, diarrhea May experience rebound autonomic activity Limited trials in NAS

Medication Morphine Starting dose (oral) 0.05 mg/kg every 3 hours (increase by 0.02 mg/kg) Dosages Tincture of opium 0.1 ml/kg (2 drops/kg) every 4 hours Methadone 0.05-0.1 mg/kg every 6-24 hours Phenobarbital 16 mg/kg loading dose, followed by 1-4 mg/kg every 12 hours as maintenance Clonidine 0.15 mcg/kg every 6 hours

Summary A standardized process should be developed for identification, evaluation, treatment and discharge management of infants with NAS Primary treatment for NAS consists of opioid replacement therapy Adjunctive agents may be considered Large, well-designed clinical trials are needed to optimize evidence-based treatment for these babies